Medications and Glucose-6-Phosphate Dehydrogenase Deficiency
- 1 September 2010
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 33 (9), 713-726
- https://doi.org/10.2165/11536520-000000000-00000
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and one of the most common genetic disorders worldwide, with an estimated 400 million people worldwide...Keywords
This publication has 94 references indexed in Scilit:
- High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) DeficiencyPLOS ONE, 2008
- Glucose-6-Phosphate Dehydrogenase Deficiency, Vitamin K, and Ambiguity in Medical TextbooksActa Haematologica, 2004
- Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxicationThe Journal of Pediatrics, 1992
- Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patientBurns, 1991
- Tolerability of Tiaprofenic Acid in Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency1Drugs, 1988
- Isosorbide Dinitrate-Induced Hemolysis in G6PD-Deficient SubjectsActa Haematologica, 1983
- Evaluation of the hemolytic role of aspirin in glucose-6-phosphate dehydrogenase deficiencyThe Journal of Pediatrics, 1976
- Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.BMJ, 1976
- Hyperlactatemia and hemolysis in G6PD deficiency after nitrofurantoin ingestionThe American Journal of the Medical Sciences, 1976
- TOXIC LIVER INJURIESActa Pathologica Japonica, 1973